Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / weight management | Not covered |
Usually no. ACA Marketplace plans rarely cover GLP-1s for weight loss. KFF read the drug lists of the federally run Marketplace plans. Only 1 percent of those plans cover Wegovy for weight loss, and none cover Zepbound for weight loss. This answer covers ACA Marketplace individual and family plans you buy yourself, including Ambetter and Oscar.
Source: KFF, Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans. Checked June 12, 2026.
If the weight-loss exclusion above applies to you, you are paying for this yourself.
Coverage by indication
Weight-loss drugs are not part of Essential Health Benefits, the set of benefits every Marketplace plan has to cover. The rule is Section 1927(d)(2) of the Social Security Act. CMS said again in January 2024 that a drug approved only for long-term weight control is not a required benefit. KFF read the 2024 drug lists of the federally run Marketplace plans. Only 1 percent cover Wegovy for weight loss, and none cover Zepbound for weight loss. The few plans that do cover a GLP-1 for obesity all make the prescriber get the plan to sign off first. Ambetter is the Centene marketplace brand, sold in 25 or more states. It follows the federal rule in nearly all of its markets and plan tiers.
Source: KFF, Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans. KFF's own read of the 2024 drug lists for the federally run Marketplace.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Start with the ACA Marketplace prior-authorization letter template, which cites this plan's policy and the diagnosis codes a reviewer looks for. Pick the indication that matches your clinical picture.
- Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
- If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly.
Frequently asked questions
Does ACA Marketplace cover GLP-1 medications?
Usually no. ACA Marketplace plans rarely cover GLP-1s for weight loss. KFF read the drug lists of the federally run Marketplace plans. Only 1 percent of those plans cover Wegovy for weight loss, and none cover Zepbound for weight loss. Policy checked June 2026.
Why is GLP-1 medications not covered?
Weight-loss drugs are not part of Essential Health Benefits, the set of benefits every Marketplace plan has to cover. The rule is Section 1927(d)(2) of the Social Security Act. CMS said again in January 2024 that a drug approved only for long-term weight control is not a required benefit. KFF read the 2024 drug lists of the federally run Marketplace plans. Only 1 percent cover Wegovy for weight loss, and none cover Zepbound for weight loss. The few plans that do cover a GLP-1 for obesity all make the prescriber get the plan to sign off first. Ambetter is the Centene marketplace brand, sold in 25 or more states. It follows the federal rule in nearly all of its markets and plan tiers.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
